nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Review of Epidermal Growth Factor Receptor/HER2 Inhibitors in the Treatment of Patients With Non–Small-Cell Lung Cancer
|
Govindan, Ramaswamy |
|
2010 |
11 |
1 |
p. 8-12 5 p. |
artikel |
2 |
Carboplatin Plus Pemetrexed as First-line Treatment of Patients With Malignant Pleural Mesothelioma: A Phase II Study
|
Katirtzoglou, Nikolaos |
|
2010 |
11 |
1 |
p. 30-35 6 p. |
artikel |
3 |
Concurrent Chemoradiation Therapy With Docetaxel/Cisplatin Followed by Docetaxel Consolidation Therapy in Inoperable Stage IIIA/B Non–Small-Cell Lung Cancer: Results of a Phase I Study
|
Huber, Rudolf M. |
|
2010 |
11 |
1 |
p. 45-50 6 p. |
artikel |
4 |
Initial Experience With Endobronchial Ultrasound in an Academic Thoracic Surgery Program
|
Bizekis, Costas S. |
|
2010 |
11 |
1 |
p. 25-29 5 p. |
artikel |
5 |
Lung Carcinogenicity of Sulfur Mustard
|
Ghanei, Mostafa |
|
2010 |
11 |
1 |
p. 13-17 5 p. |
artikel |
6 |
Oxaliplatin in First-line Therapy for Advanced Non–Small-Cell Lung Cancer
|
Raez, Luis E. |
|
2010 |
11 |
1 |
p. 18-24 7 p. |
artikel |
7 |
Plasma Nucleosome Levels Might Predict Response to Therapy in Patients With Advanced Non–Small-Cell Lung Cancer
|
Kumar, Sachin |
|
2010 |
11 |
1 |
p. 36-44 9 p. |
artikel |
8 |
Response to Pemetrexed Chemotherapy in Lung Adenocarcinoma-Bronchioloalveolar Carcinoma Insensitive to Erlotinib
|
Manson, Greg V. |
|
2010 |
11 |
1 |
p. 57-60 4 p. |
artikel |
9 |
Selected Clinical Trials in First-line Metastatic Non–Small-Cell Lung Cancer
|
Langer, Corey J. |
|
2010 |
11 |
1 |
p. 61-62 2 p. |
artikel |
10 |
Subsequent Chemotherapy Improves Survival Outcome in Advanced Non–Small-Cell Lung Cancer With Acquired Tyrosine Kinase Inhibitor Resistance
|
Kuo, Chih-Hsi |
|
2010 |
11 |
1 |
p. 51-56 6 p. |
artikel |